4//SEC Filing
Golembiewski Michael Joseph 4
Accession 0001104659-24-030070
CIK 0001017491other
Filed
Feb 29, 7:00 PM ET
Accepted
Mar 1, 5:39 PM ET
Size
5.4 KB
Accession
0001104659-24-030070
Insider Transaction Report
Form 4
Golembiewski Michael Joseph
Chief Financial Officer
Transactions
- Award
Common Stock
2024-02-29$1.10/sh+417$457→ 86,869 total
Footnotes (2)
- [F1]These shares were acquired under the Company's 2020 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c).
- [F2]Effective on November 28, 2023, the Issuer conducted a reverse stock split at a ratio of 1-for-30 (the "Reverse Split"). The number of shares reported herein reflects the number of shares after the Reverse Split.
Documents
Issuer
SEELOS THERAPEUTICS, INC.
CIK 0001017491
Entity typeother
Related Parties
1- filerCIK 0001639479
Filing Metadata
- Form type
- 4
- Filed
- Feb 29, 7:00 PM ET
- Accepted
- Mar 1, 5:39 PM ET
- Size
- 5.4 KB